Alliance for Human Research Protection

AHRP Honors Exemplary Professionals

Fred Baughman, MD

Fred A. Baughman, Jr.

Carl Elliott, MD

Carl Elliott, MD

Curt D. Furberg, MD

Curt D. Furberg, MD

David Graham, MD

David Graham, MD

Diane Harper, MD

Diane Harper, MD

Bernadine Healy, MD

Bernadine Healy, MD

Anthony Morris, MD

Anthony Morris, MD

Loren Mosher, MD

Loren Mosher, MD

Florence Nightingale

Florence Nightingale

Nancy Olivieri, MD

Nancy Olivieri, MD

Maurice Pappworth, MD

Maurice Pappworth

John Pesando, MD

John Pesando, MD

Jacob Puliyel, MD

Jacob Puliyel, MD

John Thompson, MD

John Thompson, MD

Dr. Andrew Wakefield

Dr. Andrew Wakefield

Primary Menu

Skip to content

About
Categories
Medical Ethics
Medical Atrocities
Current Controversies
Vaccines
- Unsafe Vaccines
- Vaccine mandates

Drugs

Real Men, Real Depression—-Marketing Masquerading as Medical News_Newsweek

February 19, 2007 |

The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH)— Continue reading →

Categorized Psych Drugs | Tagged Mental Health screening, TeenScreen, depression, Bi-Polar, hallucinations, deep brain stimulation, Harvard, Drugs, Eli Lilly, disease mongering, Serotonin, Pfizer

The FDA and Drug Safety: A Proposal for Sweeping Changes

October 11, 2006 |

A Special Article By Curt D. Furberg, MD, PhD; Arthur A. Levin, MPH; Peter A. Gross, MD; Robyn S. Shapiro, JD; Brian L. Strom, MD, MPH

Continue reading →

Categorized Rx. Drugs | Tagged Prescription for Disaster, Medicare, Safety Issues, FDA, Peer Review, Senator Grassley, Advisory Committee, stimulants, unsafe drugs, Vioxx, Merck, Drugs, Bioethics, litigation, JAMA, black box warning, diabetes, Adverse Drug Reaction, Serotonin, Statin

Aid Our Efforts: Donate!

Make a tax-deductible contribution today.

Sign up for our Newsletter.

Receive email updates from AHRP.

Board Member: David Egilman, MD

1. Expert witness David Egilman wins billions—and makes enemies—as he fights companies over public health, Science Magazine 2019

2. Court Records Show How a Medical Device ‘Seeding Trial’ Disguised Marketing as Science Health News Review,2018

3. J&J seeks retraction of paper critical of Pinnacle hip study

4. Grave fraudulence in medical device research: a narrative review of the PIN seeding study for the Pinnacle hip system, Accountability in Research 2018; Joan E. Steffen, B.A., Ella A. Fassler, B.S., Kevin J. Reardon, M.A., & David S. Egilman, M.D., M.P.H.

5. Artificial Hip Maker Demands Retraction Of A Paper Calling Its Research ‘Grave Fraudulence’ STAT News 2018

6. Corporate Corruption of Science—Another Asbestos Example, American Journal of Industrial Medicine

7. Sudden Shift at a Public Health Journal Leaves Scientists Feeling Censored ProPublica

8. ‘YOU WANT A DESCRIPTION OF HELL?’ OXYCONTIN’S 12-HOUR PROBLEM, Los Angeles Times, 2016 Excerpt: For a brief moment three years ago, it seemed the problems with 12-hour dosing might get wider attention. The FDA had called for public input on how to make painkiller labels safer. Dr. David Egilman, a Brown University professor of family medicine who had served as a plaintiff’s expert in unsuccessful suits against Purdue, saw it as an opportunity to alert agency officials to problems with OxyContin’s 12-hour claim.

Donate to AHRP

To make a tax-deductible contribution, you may use Paypal:

Or mail your check, payable to AHRP:

Alliance for Human Research Protection (AHRP)
142 West End Ave., Suite 28P
New York, NY 10023

Random Quote

When you think of the long and gloomy history of man, you find more hideous crimes have been committed in the name of obedience than have ever been committed in the name of rebellion.

— C.P. Snow

Proudly powered by WordPress

Copyright © 2019 Alliance for Human Research Protection. All Rights Reserved.